The U.S. Food and Drug Administration (FDA) recently approved Tyruko (natalizumab-sztn, made by Sandoz, a division of the Novartis group). Tyruko is the first biosimilar disease-modifying therapy (DMT) for individuals…
Read More
A study just published in the journal Neurology shows that if exposed to West Nile Virus (WNV) infection, individuals taking anti-CD20 disease modifying therapies (DMTs) used in treatment of MS…
The summer season is officially in full swing and that means much warmer temperatures. If you are having more problems with your MS during these warmer months, you’re not alone….
The Rural Engagement Program (REP) at the MS Center aims to increase access to support resources for people impacted by MS living throughout rural Colorado. In addition, the rural engagement…
At the Rocky Mountain MS Center, we are always striving to learn more about what our clients and families are experiencing to help us identify how best to serve you….
UPDATED JUNE 15, 2023: The Copay Accumulator bill (SB-195) to protect co-pay assistance for patients passed the Colorado State Legislature and has now been signed by Governor Polis. This bill ensures…
April 16-24, 2023 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
April 16-24, 2023 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
April 16-24, 2023 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
April 16-24, 2023 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…